On July 21, Akeso Bio fell 3.05% in regular trading, trading at HK$90.5/share, with turnover of HK$193 million.
Within the Biotechnology sector where Akeso Bio belongs, the overall sector performance was weak. Among individual stocks, BeiGene down 2.09%, Innovent Bio down 2.38%, SKB Bio down 0.60%, 3SBio down 2.07%, Remegen down 3.10%.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)